News Releases

scPharmaceuticals Inc. to Present at Upcoming Investor Conferences
BURLINGTON, Mass. --(BUSINESS WIRE)--May 28, 2020-- scPharmaceuticals Inc. (Nasdaq:SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today[…]
scPharmaceuticals Announces Pricing of Public Offering of Common Stock
BURLINGTON, Mass. --(BUSINESS WIRE)--May 20, 2020-- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today[…]
scPharmaceuticals Inc. Announces Proposed Underwritten Public Offering of Common Stock
BURLINGTON, Mass. --(BUSINESS WIRE)--May 20, 2020-- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today[…]
scPharmaceuticals Inc. Reports First Quarter 2020 Financial Results and Provides Business Update
Remain on track to resubmit FUROSCIX® NDA with the FDA by mid-year 2020 Strong balance sheet with over $75M in cash Projected annual loss for 2020 narrows to $36-40M BURLINGTON, Mass. --(BUSINESS WIRE)--May 12, 2020-- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on[…]
scPharmaceuticals Inc. Reports Fourth Quarter and Year Ended 2019 Financial Results and Provides Business Update
Remain on track to resubmit FUROSCIX ® NDA with the FDA by mid-year 2020 Initiating FUROSCIX pre-commercialization and product positioning efforts Strong balance sheet; ending 2019 with $72.8 million in cash Guiding 2020 quarterly GAAP expenses of $9.0 to $11.0 million BURLINGTON, Mass.[…]
scPharmaceuticals Inc. to Present at the Cowen and Company’s 40th Annual Health Care Conference
BURLINGTON, Mass. --(BUSINESS WIRE)--Feb. 26, 2020-- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs, today[…]
scPharmaceuticals Inc. to Present at the 9th Annual SVB Leerink Global Healthcare Conference
BURLINGTON, Mass. --(BUSINESS WIRE)--Feb. 20, 2020-- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs, today[…]